We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Pelvic Floor and Hip Muscle Strengthening in the Treatment of Stress Urinary Incontinence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01948713
Recruitment Status : Completed
First Posted : September 24, 2013
Last Update Posted : April 6, 2017
Sponsor:
Information provided by (Responsible Party):
University of Sao Paulo General Hospital

Brief Summary:
INTRODUCTION: Stress urinary incontinence is a common condition in women and can be defined as the involuntary loss of urine on exertion, exercise, sneezing or coughing. This pathology causes physical discomfort and impacts the quality of life in a negative manner. Physiotherapeutic exercises is a treatment with low cost and high patient attendance. It can be applied with focus on strengthening the pelvic floor muscles or on muscular synergism. OBJECTIVE: To compare the effectiveness of Kegel exercises performed alone or performed in association with the strengthening of the muscles of the hip in the treatment of stress urinary incontinence. METHODOLOGY: The study is a randomized, blinded clinical trial. It aims at assessing objectively the strength of the pelvic floor, the improvement in the number of episodes of loss and impact on quality of life. The study will accept up to 40 women, who will be divided into two groups of physical therapy: group 1 (that will strengthen the pelvic floor muscles with Kegel exercises) and group 2 (that will perform strengthening the pelvic floor muscles with Kegel exercises associated with the strengthening of muscles of the hip). The two groups will be evaluated at the beginning and at the end of treatment.

Condition or disease Intervention/treatment Phase
Stress Urinary Incontinence Other: Strengthening of pelvic floor muscles. Other: Strengthening of hip muscles. Not Applicable

Detailed Description:
the strength of the pelvic floor muscles will be evaluated with the aid of a perineometer

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 43 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of Pelvic Floor and Hip Muscle Strengthening in the Treatment of Stress Urinary Incontinence: Randomized Blind Clinical Trial
Actual Study Start Date : January 7, 2013
Actual Primary Completion Date : September 18, 2014
Actual Study Completion Date : January 8, 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Group 1
Strengthening of pelvic floor muscles.
Other: Strengthening of pelvic floor muscles.
Kegel exercises kinesiotherapy

Experimental: Group 2
Strengthening of pelvic floor muscles associated with strengthening of hip muscles.
Other: Strengthening of pelvic floor muscles.
Kegel exercises kinesiotherapy

Other: Strengthening of hip muscles.
Kegel exercises and strengthening of hip muscles as Gluteus Maximus and Medius and adductor muscles




Primary Outcome Measures :
  1. Change in frequence of urinary incontinence [ Time Frame: At the first session of physical therapy and after 10 weeks of physical therapy treatment a voiding diary will be applied, and every session a follow up diary will be used. The physiotherapy treatment will be held twice a week for 10 weeks. ]
    number of episodes of urinary leakage per week


Secondary Outcome Measures :
  1. Change in strength of pelvic floor muscles [ Time Frame: At the first session of physical therapy and after 10 weeks of physical therapy treatment . The physiotherapy treatment will be held twice a week for 10 weeks. ]
    The strength of pelvic floor muscles will be assessed qualitatively by the functional evaluation of pelvic floor and quantitatively by perineometer.

  2. Change in quality of life [ Time Frame: At the first session of physical therapy and after 10 weeks of physical therapy treatment . The physiotherapy treatment will be held twice a week for 10 weeks. ]
    Questionnaires: International Consultation on Incontinence Questionnaire (ICIQ); King´s Health Questionnaire (KHQ)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Women with 30 to 70 years of age;
  • Clinical diagnosis of stress urinary incontinence;
  • Urodynamic study.

Exclusion Criteria:

  • Stress urinary incontinence with sphincter deficiency;
  • Urinary urgence;
  • Mixed urinary incontinence;
  • Pregnant women;
  • Neurological or muscular disease that interfere with continence;
  • Urinary infection;
  • Genital prolapse;
  • Gynecological surgery for urinary incontinence in the last year;
  • Hormone replacement therapy;
  • Strength 0 in functional evaluation of the pelvic floor muscles.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01948713


Locations
Layout table for location information
Brazil
University of Sao Paulo General Hospital
Sao Paulo, Brazil, 05403000
Sponsors and Collaborators
University of Sao Paulo General Hospital
Investigators
Layout table for investigator information
Principal Investigator: Simone A. Marques, researcher University of Sao Paulo
Layout table for additonal information
Responsible Party: University of Sao Paulo General Hospital
ClinicalTrials.gov Identifier: NCT01948713    
Other Study ID Numbers: SimoneM
First Posted: September 24, 2013    Key Record Dates
Last Update Posted: April 6, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Incontinence
Enuresis
Urinary Incontinence, Stress
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Behavioral Symptoms
Elimination Disorders
Mental Disorders